Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study

OBJECTIVE: Local combined systemic therapy has been an important method for the treatment of unresectable hepatocellular carcinoma (HCC).The purpose of this study was to compare the effectiveness and safety of transarterial chemoembolization (TACE) plus Sorafenib versus TACE plus Apatinib for treati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Liang, Liu, Kai-Cai, Lv, Wei-Fu, Lu, Dong, Tan, Yu-Lin, Wang, Guo-Xiang, Dai, Jia-Ying, Zhu, Xian-Hai, Jiang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230673/
https://www.ncbi.nlm.nih.gov/pubmed/37254146
http://dx.doi.org/10.1186/s40644-023-00574-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230673/
https://www.ncbi.nlm.nih.gov/pubmed/37254146
http://dx.doi.org/10.1186/s40644-023-00574-7

Ejemplares similares